NR-565 Final Exam Study Guide 2026/2027 Questions & Answers: Diabetes, Insulin, Thyroid & Endocrine Pharmacology | Chamberlain University

This NR-565 Final Exam Study Guide 2026/2027 is a focused 9-page advanced pharmacology review containing exam-style questions, answers, and high-yield study prompts on diabetes mellitus, insulin therapy, antidiabetic medications, thyroid disorders, and endocrine pharmacology. The document begins with multiple-choice questions before transitioning into concise question-and-answer review points. Major areas include medications associated with hypoglycemia, pioglitazone contraindications, hyperthyroidism symptom management, thyroid storm, thiazolidinediones, GLP-1 receptor agonists, and general diabetes-management goals. NR565 Final Exam Study Guide 20… The diabetes pharmacology section emphasizes medication mechanisms and safe treatment selection. Students review insulin therapy, thiazolidinediones (TZDs), GLP-1 receptor agonists, DPP-4 inhibitors, sulfonylureas, and SGLT2 inhibitors, including their mechanisms of action and the identification of diabetes medications associated with hypoglycemia. The guide also addresses confirmation of a diabetes diagnosis before treatment, interpretation and clinical use of A1C, general treatment goals, diabetes targets in older adults, indications for initiating insulin, reassessment intervals, and the physiologic action of insulin. NR565 Final Exam Study Guide 20… Insulin-focused review includes basal and rapid-acting insulin concepts, total daily dose (TDD), basal-to-rapid insulin proportions, and carbohydrate-to-insulin relationships. These topics make the resource useful for students preparing to distinguish insulin-management principles from the pharmacologic actions of non-insulin antidiabetic agents. The document also specifically identifies pioglitazone contraindications as an exam topic and contrasts the mechanisms of TZDs, GLP-1 agonists, DPP-4 inhibitors, sulfonylureas, and SGLT2 inhibitors. NR565 Final Exam Study Guide 20… The thyroid pharmacology section reviews laboratory evaluation used in diagnosing thyroid conditions, the timing of laboratory reassessment after initiating levothyroxine, and the characteristic signs and symptoms of hypothyroidism and hyperthyroidism. High-yield final-exam concepts include pharmacologic management of thyroid storm, medications used for symptomatic control of hyperthyroidism, drug-food-supplement interactions involving levothyroxine, and the consequences of untreated hypothyroidism during pregnancy. NR565 Final Exam Study Guide 20… Overall, the guide is designed as a concise final-exam review rather than a comprehensive pharmacology textbook. Its strongest coverage is concentrated on endocrine prescribing and medication management, particularly diabetes and thyroid disease. Because several later entries are presented as study prompts rather than fully elaborated answers, students can use the document as a checklist for identifying the endocrine pharmacology concepts requiring further review before the NR-565 final. NR565 Final Exam Study Guide 20… Relevant students: This document is relevant to NR-565 students, Family Nurse Practitioner (FNP) students, Adult-Gerontology Nurse Practitioner students, MSN students, DNP students, advanced-practice registered nursing students, and nurse practitioner students studying advanced pharmacology. It is particularly applicable to learners preparing for final-exam questions involving endocrine medications, diabetes treatment, insulin management, antidiabetic drug classes, thyroid laboratory monitoring, levothyroxine, hyperthyroidism, and thyroid storm. Keywords: NR 565 final exam, NR565 final exam study guide, NR 565 final exam , NR565 questions and answers, NR 565 study guide, advanced pharmacology final exam, endocrine pharmacology, diabetes pharmacology, diabetes medications, insulin therapy, insulin dosing, basal insulin, rapid acting insulin, total daily insulin dose, carbohydrate insulin ratio, hypoglycemia medications, A1C diabetes, diabetes management goals, older adult diabetes management, pioglitazone contraindications, thiazolidinediones, TZD mechanism of action, GLP 1 receptor agonists, DPP 4 inhibitors, sulfonylureas, SGLT2 inhibitors, thyroid pharmacology, thyroid laboratory tests, hypothyroidism, hyperthyroidism, levothyroxine, levothyroxine interactions, thyroid storm treatment, hypothyroidism in pregnancy, nurse practitioner pharmacology, FNP pharmacology, Chamberlain NR 565